Synapsoft logo
AI Insights from Disclosures
Searching...
Medy-Tox Inc. 086900
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Medy-Tox Inc. engages in the research, development, manufacture, and sale of Clostridium botulinum Toxin Type A and biopharmaceuticals using botulinum toxin as its main business. Its flagship product, the botulinum toxin type A drug Meditoxin (Neuronox), is a product developed with the company's own original source technology, the fourth of its kind in the world.
Representative Director Jung Hyeonho
Founded May 2, 2000
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 16481-0016928
Business number 312-81-42130
Phone Number 043-217-1555
Fax Number 043-217-1557
Website www.medytox.com
Company Address 충청북도 청원군 오창읍 각리1길 78 (주)메디톡스
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant